Justices Order Court that Hears Patent Cases to Reconsider Decision That Limited Access to Crucial Genetic Testing
NEW YORK–(ENEWSPF)–March 26, 2012. The U.S. Supreme Court today set aside a ruling that allowed a company to patent two genes linked to breast and ovarian cancer and limit access to potentially life-saving genetic tests for at-risk women.
The American Civil Liberties Union and the Public Patent Foundation (PUBAT) have challenged the patents held by Myriad Genetics on…
